Efficacy of Distant Healing in Glioblastoma Treatment
NCT00029783 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2006-08-18
Summary
This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.
Conditions
Interventions
- PROCEDURE
-
Distant Healing
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
lead NIH
Principal Investigators
-
Andrew Freinkel, MD · California Pacific Medical Center Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Completion
- 2005-06-30
Countries
- United States
Study Locations
More Related Trials
-
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496 ·Status: RECRUITING
-
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
NCT00004659 ·Status: UNKNOWN ·Phase: PHASE2
-
Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner
NCT02129335 ·Status: TERMINATED
-
Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
NCT05990556 ·Status: RECRUITING ·Phase: NA
-
Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
NCT05941234 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
NCT02329795 ·Status: TERMINATED
-
Evaluation of Factors in Human Brain Tumors
NCT00001171 ·Status: COMPLETED
-
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 ·Status: COMPLETED
-
Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields
NCT03501134 ·Status: COMPLETED
-
Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
NCT06430424 ·Status: RECRUITING
-
Gut Microbiota and Glioblastoma Multiforme Prognosis
NCT03631823 ·Status: UNKNOWN
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
NCT05296122 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy
NCT02913534 ·Status: COMPLETED
-
Stereotactic Radiotherapy of the Resection Cavity of Brain Metastases vs. Post-operative Whole-brain Radiotherapy
NCT03285932 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
NCT01821443 ·Status: TERMINATED ·Phase: NA
-
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
NCT02953756 ·Status: COMPLETED
-
The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier
NCT04063514 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Tumor Electric Fields Treatment System for Glioblastoma
NCT04417933 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PH Sensitive MRI Based Resections of Glioblastoma
NCT06176066 ·Status: RECRUITING ·Phase: PHASE1
-
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
NCT01579253 ·Status: UNKNOWN
-
Image-Guided Stereotactic Biopsy of High Grade Gliomas
NCT00979810 ·Status: COMPLETED ·Phase: NA
-
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
NCT02375841 ·Status: ACTIVE_NOT_RECRUITING
-
A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
NCT06215495 ·Status: RECRUITING ·Phase: NA